---
$id: https://graph.org.ai/products/commodity/51101629
$type: Product
source: UNSPSC
code: "51101629"
title: "Trimetrexate"
class: "51101600"
classTitle: "Amebicides and trichomonacides"
family: "51100000"
familyTitle: "Amebicides and trichomonacides and antiprotozoals"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Trimetrexate

**UNSPSC Code**: 51101629
**Class**: [Amebicides and trichomonacides](Amebicides and trichomonacides.mdx)
**Family**: [Amebicides and trichomonacides and antiprotozoals](../Amebicides and trichomonacides and antiprotozoals.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a folate antagonist and dihydrofolate reductase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UPN4ITI8T4. European Medicines Agency schedules Trimetrexate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11312MIG. Trimetrexate generally arises in the molecular formula C19H23N5O3. The term TRIMETREXATE is an International Non-Proprietary Name or INN. TRIMETREXATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule trimetrexate under HS 29335995 and SITC 51576. As of Q4 2014, TRIMETREXATE remains the US FDA Preferred Term for this commodity. Trimetrexate bears US NLM identifiers UMLS ID C0085176 and NCI Concept Code C1314. SMILES: O(C1CC(NCC2C(C3C(NC([NH]C3N)N)CC2)C)CC(OC)C1OC)C.

